We are live on
!
Find out more
CF
Concorde Financial Portfolio holdings
AUM
$124M
1-Year Est. Return
25.7%
This Fund
S&P 500
This Quarter
Est. Return
+13.87%
1 Year Est. Return
+25.7%
3 Year Est. Return
+81.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$148M
AUM Growth
+$318
(+0%)
Cap. Flow
-$497K
Cap. Flow
% of AUM
-0.34%
Top 10 Holdings %
Top 10 Hldgs %
46.94%
Holding
58
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortune Brands Innovations
FBIN
|
+$497K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 24.11% |
| 2 | Miscellaneous | 13.95% |
| 3 | Healthcare | 11.23% |
| 4 | Industrials | 10.82% |
| 5 | Consumer Discretionary | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Texas Pacific Land
TPL
$25.5B
| $13.7M | 9.27% |
69,624
| – | – |
|
2
Sprott Physical Gold
PHYS
$15.6B
| $11.6M | 7.79% |
902,448
| – | – |
|
3
Microsoft
MSFT
$3.68T
| $6.26M | 4.22% |
26,899
| – | – |
|
|
PXD
4
DELISTED
Pioneer Natural Resource Co.
PXD
| $6.23M | 4.2% |
28,759
| – | – |
|
5
JPMorgan Ultra-Short Income ETF
JPST
$41.1B
| $5.92M | 3.99% |
118,041
| – | – |
|
6
AbbVie
ABBV
$454B
| $5.62M | 3.79% |
41,889
| – | – |
|
7
Johnson & Johnson
JNJ
$640B
| $5.25M | 3.54% |
32,118
| – | – |
|
8
Hubbell
HUBB
$24.3B
| $5.24M | 3.53% |
23,498
| – | – |
|
9
ExxonMobil
XOM
$683B
| $5.21M | 3.51% |
59,640
| – | – |
|
10
Hershey
HSY
$34.8B
| $4.57M | 3.08% |
20,742
| – | – |
|
11
Franco-Nevada
FNV
$51.3B
| $4.5M | 3.04% |
37,603
| – | – |
|
12
Amazon
AMZN
$2.77T
| $4.39M | 2.96% |
38,872
| – | – |
|
13
Lowe's Companies
LOW
$110B
| $4.04M | 2.72% |
21,513
| – | – |
|
14
JPMorgan Chase
JPM
$947B
| $3.96M | 2.67% |
37,899
| – | – |
|
15
Bunge Global
BG
$23.5B
| $3.86M | 2.61% |
46,784
| – | – |
|
16
SLB Ltd
SLB
$83.2B
| $3.84M | 2.59% |
106,313
| – | – |
|
17
TJX Companies
TJX
$139B
| $3.54M | 2.39% |
57,066
| – | – |
|
18
Kinder Morgan
KMI
$68.7B
| $3.23M | 2.18% |
194,014
| – | – |
|
19
DuPont de Nemours
DD
$17.1B
| $3.14M | 2.12% |
49,614
| – | – |
|
20
Northrop Grumman
NOC
$73.7B
| $3.07M | 2.07% |
6,519
| – | – |
|
|
21
Fortune Brands Innovations
FBIN
$4.86B
| $2.99M | 2.02% |
55,672
-9,464
| -15% | -$497K |
|
22
First Industrial Realty Trust
FR
$8.14B
| $2.75M | 1.86% |
60,991
| – | – |
|
23
Encompass Health
EHC
$12B
| $2.67M | 1.8% |
58,754
| – | – |
|
24
Comcast
CMCSA
$89.4B
| $2.66M | 1.79% |
90,686
| – | – |
|
25
Moderna
MRNA
$57.5B
| $2.63M | 1.78% |
22,260
| – | – |
|
Similar funds
PFG
PHWM
CCMG
SFP
OFS
EI
MFS
BC
Concorde Financial's Q4 2022 Portfolio in Review
As of Q4 2022, Concorde Financial held 58 positions worth $148M, up 0% from $148M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Trading was light in Q4 2022: portfolio turnover was 0%. Concorde Financial opened no new positions and made no exits, leaving the 58-position portfolio largely intact.
By sector, the portfolio is most concentrated in Energy at 24% of assets, up from 24% a quarter earlier, followed by Miscellaneous and Healthcare.
- Concorde Financial's biggest Q4 2022 reduction was Fortune Brands Innovations, cutting an estimated $497K.
- Concorde Financial's ten largest holdings make up 47% of its $148M portfolio in Q4 2022.
- Concorde Financial opened 0 new positions and closed 0 in Q4 2022.
- Concorde Financial's portfolio value rose 0% quarter-over-quarter to $148M.
Based on Concorde Financial's 13F filing for Q4 2022, filed 14 Feb 2023.